Blood News and Research

RSS

Researchers release results of (STAR) breast cancer prevention trial

Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.

18 Apr 2006

Study is the first to show that stature influences atrial fibrillation risk

Analysis of data from a registry of patients with left ventricular dysfunction indicates that height is an independent risk factor for an arrhythmia of the upper chambers of the heart, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.

17 Apr 2006

Almost half of elderly Beijing residents have metabolic syndrome

As more people in China adopt Western diets and lifestyles, many are developing a cluster of cardiovascular disease risk factors, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.

17 Apr 2006

Placental growth factor may help body repair heart attack damage

Heart attack patients produce higher levels of a natural substance in the body that plays a role in the growth of new blood vessels and this over-expression of placental growth factor (PlGF) may help reduce damage to the heart muscle

17 Apr 2006

Laparoscopic partial nephrectomy for centrally located renal tumors

The Cleveland Clinic Group has shown that with experience they have been able to effectively offer laparoscopic partial nephrectomy (LPN) to more patients with centrally located lesions.

17 Apr 2006

Evista may be a better option than Tamoxifen for reducing breast cancer risk

According to drug company Lilly it's osteoporosis drug Evista is as effective as Tamoxifen in reducing the risk of breast cancer in high-risk women.

17 Apr 2006

Genetic testing helps diagnose Long QT syndrome

Long QT syndrome is an uncommon, and sometimes fatal, heart rhythm disorder that is often present from birth. It gets its name from the peculiar pattern of the electrocardiogram (ECG or EKG) seen in people with the disease. It affects one in every 3,000 people in the United States.

16 Apr 2006

Hap1 protein could lead to future drug targets for eating disorders

Researchers have discovered how the protein Hap1, which is abundant in the brain's hypothalamus, serves as the link between circulating insulin in the blood and the neural circuitry that controls feeding behavior in mice.

16 Apr 2006

Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6

A novel growth factor significantly improves the ability of specialized stem cells derived from human fat to be transformed into cartilage cells, according to Duke University Medical Center and Pratt School of Engineering researchers.

16 Apr 2006

Diabetes: Translating the chronic care model into the community

Educating people with diabetes in a primary-care setting with sustained, comprehensive intervention resulted in significant improvement in disease management and overall health, according to a study published in the current issue of Diabetes Care, a journal of the American Diabetes Association (ADA).

16 Apr 2006

Approval of integrated insulin pump and continuous glucose system a significant step towards artificial pancreas technology

The Juvenile Diabetes Research Foundation (JDRF) has said that the federal government's approval of an insulin pump that also provides real-time, continuous glucose monitoring is a significant step on the path to the development of an artificial pancreas, with the potential to significantly improve diabetes care and lower the risk of complications.

13 Apr 2006

Cholesterol-lowering drug might not promote healthy hearts

Antioxidants, such as beta-carotene and Vitamin E, have been touted for their ability to protect against heart disease.

13 Apr 2006

Loneliness is a unique predictor of age-related differences in systolic blood pressure

Loneliness is a major risk factor in increasing blood pressure in older Americans, and could increase the risk of death from stroke and heart disease, new research at the University of Chicago shows.

13 Apr 2006

Angiotension-converting enzyme inhibitors may reduce cardiovascular risk

Angiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease, according to a new analysis of previously conducted clinical trials reported in the Archives of Internal Medicine.

13 Apr 2006

Blood News and Research

Researchers release results of (STAR) breast cancer prevention trial

Study is the first to show that stature influences atrial fibrillation risk

Almost half of elderly Beijing residents have metabolic syndrome

Placental growth factor may help body repair heart attack damage

Laparoscopic partial nephrectomy for centrally located renal tumors

Evista may be a better option than Tamoxifen for reducing breast cancer risk

Genetic testing helps diagnose Long QT syndrome

Hap1 protein could lead to future drug targets for eating disorders

Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6

Diabetes: Translating the chronic care model into the community

Approval of integrated insulin pump and continuous glucose system a significant step towards artificial pancreas technology

Cholesterol-lowering drug might not promote healthy hearts

Loneliness is a unique predictor of age-related differences in systolic blood pressure

Angiotension-converting enzyme inhibitors may reduce cardiovascular risk

Compounds derived from legume interaction with rhizobium bacteria may help cancer treatment

Simple screening process opens door to treating rare metabolic diseases such as Tay-Sachs, Fabry and Gaucher syndromes

First evidence that circulating endothelial microparticles lead to heart valve disease

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

Research provides clues to obesity's cause

Maintaining high blood pressure treatment may reduce the risk of dementia in old age

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News